Tower Research Capital »

Keros Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $225k 4.9k 45.67
2024-03-31 $59k 895 66.20
2023-09-30 $20k 637 31.90
2023-06-30 $79k 2.0k 40.18
2023-03-31 $48k 1.1k 42.33
2022-12-31 $0 486 0.00
2022-09-30 $0 2.8k 0.00
2022-06-30 $100k 3.6k 27.58
2022-03-31 $21k 377 55.70
2021-12-31 $101k 1.7k 60.00
2021-09-30 $19k 484 39.26
2021-06-30 $46k 1.0k 45.05
2021-03-31 $35k 562 62.28
2020-12-31 $14k 192 72.92
2020-09-30 $247k 6.4k 38.60
2020-06-30 $13k 347 37.46